Simplex Trading’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,400
Closed -$1K 9286
2022
Q4
$1K Hold
1,400
﹤0.01% 8813
2022
Q3
$1K Hold
1,400
﹤0.01% 9517
2022
Q2
$1K Sell
1,400
-100
-7% -$222 ﹤0.01% 9560
2022
Q1
$4K Sell
1,500
-4,900
-77% -$11.8K ﹤0.01% 9542
2021
Q4
$18K Sell
6,400
-300
-4% -$1.12K ﹤0.01% 8465
2021
Q3
$42K Sell
6,700
-3,900
-37% -$20K ﹤0.01% 7722
2021
Q2
$63K Buy
+10,600
New +$39.2K ﹤0.01% 7360

Other funds holding ENTX

Simplex Trading's ENTX Position: Q4 2025 in Review

Simplex Trading sold out of Entera Bio (ENTX) in Q4 2025, closing a stake of 69 shares.

Simplex Trading first reported a position in ENTX in Q2 2021 and held it in 9 quarters. The position peaked at $122K in Q3 2021. 22 funds tracked by Wall St. Rank hold ENTX as of Q4 2025.

  • Simplex Trading reported no remaining Entera Bio position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 69 Entera Bio shares in Q4 2025.
  • Simplex Trading first reported a position in Entera Bio in Q2 2021 and held it in 9 quarters.
  • Simplex Trading's Entera Bio position peaked at $122K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Entera Bio as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.